13 Feb 2006 : Column 1758Wcontinued
Disabled People (Independent Living)
Mr. Hunt:
To ask the Secretary of State for Health what the outcome was of the consultation referred to in Improving the Life Chances of Disabled People on
13 Feb 2006 : Column 1759W
whether people should have a right to request not to live in residential or nursing care; and if she will make a statement. [49830]
Mr. Byrne
[holding answer 7 February 2006]: Consultation on whether people should have the right to request not to live in residential or nursing care was included in the adult social care Green Paper Independence Well-being and Choice: our vision for the future of social care for adults in England" which ran between 21 March and 28 July 2005.
An analysis of this consultation was published on 19 October 2005 and is available in the Library.
13 Feb 2006 : Column 1760W
Domiciliary Care
Mr. Burstow:
To ask the Secretary of State for Health how many people over the age of 65 years were supported to live at home in (a) England and (b) each strategic health authority in each year since 1997. [47935]
Mr. Byrne:
Information on the number of older people aged 65 or over helped to live at home in England and each strategic health authority as at 31 March, for the years 199899 to 200405 is shown in the table.
Following the last spending review, the Department was expected to ensure that, by March 2006, the number of older people supported intensively to live at home increased to 30 per cent. of the total being supported by social services at home or in residential care. This target was met two years early, in 200304, when the national average reached 30.1 per cent.
Number of older people aged 65 or over helped to live at home(54) by strategic health authority (SHA), 199899 to 200405(55)England
Rounded numbers
|
---|
| 199899 | 19992000 | 200001 | 200102 | 200203 | 200304 | 200405(56)
|
England total | 637,600 | 662,000 | 649,700 | 660,200 | 660,700 | 662,000 | 641,900
|
| | | | | | |
|
SHA | | | | | | |
|
Avon, Gloucestershire and Wiltshire | 23,900 | 31,300 | 30,100 | 27,300 | 26,100 | 26,300 | 23,200
|
Bedfordshire and Hertfordshire | 11,700 | 12,000 | 13,700 | 14,800 | 15,000 | 19,000 | 16,800
|
Birmingham and the Black Country | 35,000 | 32,400 | 29,700 | 30,900 | 28,300 | 26,500 | 24,400
|
Cheshire and Merseyside | 27,100 | 29,800 | 32,700 | 34,800 | 34,400 | 35,300 | 34,900
|
County Durham and Tees Valley | 15,100 | 17,500 | 15,100 | 17,000 | 17,200 | 17,400 | 18,700
|
Cumbria and Lancashire | 25,300 | 22,700 | 22,600 | 25,300 | 26,300 | 25,000 | 25,300
|
Dorset and Somerset | 17,100 | 15,100 | 18,200 | 19,000 | 17,500 | 18,500 | 17,100
|
Essex | 14,000 | 36,600 | 15,500 | 17,400 | 20,400 | 23,300 | 26,700
|
Greater Manchester | 38,300 | 42,900 | 40,000 | 42,400 | 37,800 | 37,300 | 36,300
|
Hampshire and Isle of Wight | 17,200 | 17,300 | 15,200 | 23,800 | 19,600 | 23,800 | 23,900
|
Kent and Medway | 19,000 | 15,100 | 15,500 | 16,800 | 20,700 | 22,500 | 18,600
|
Leicestershire, Northamptonshire and Rutland | 16,000 | 17,400 | 16,100 | 18,000 | 18,700 | 19,100 | 20,600
|
N and E Yorkshire and N Lincolnshire | 21,000 | 13,300 | 20,900 | 23,100 | 25,700 | 24,700 | 24,600
|
Norfolk, Suffolk and Cambridgeshire | 20,700 | 22,000 | 20,700 | 23,900 | 24,800 | 26,800 | 29,100
|
North Central London | 12,500 | 13,300 | 12,500 | 14,900 | 14,200 | 13,400 | 11,900
|
North East London | 26,100 | 22,000 | 16,400 | 17,600 | 18,000 | 18,000 | 19,000
|
North West London | 22,900 | 20,400 | 19,400 | 18,100 | 18,900 | 20,400 | 19,400
|
Northumberland, Tyne and Wear | 25,200 | 30,300 | 30,100 | 27,500 | 29,100 | 28,200 | 25,700
|
Shropshire and Staffordshire | 22,000 | 28,600 | 30,000 | 20,800 | 21,000 | 21,000 | 26,700
|
South East London | 21,800 | 23,500 | 21,400 | 20,700 | 20,600 | 19,200 | 18,600
|
South West London | 17,100 | 17,100 | 17,600 | 17,300 | 17,100 | 16,300 | 14,000
|
South West Peninsula | 19,100 | 21,100 | 22,500 | 24,500 | 26,700 | 23,200 | 22,000
|
South Yorkshire | 16,300 | 23,900 | 23,000 | 19,300 | 19,300 | 17,100 | 18,100
|
Surrey and Sussex | 26,700 | 28,400 | 34,200 | 33,400 | 30,000 | 27,700 | 21,700
|
Thames Valley | 22,100 | 17,300 | 18,500 | 19,900 | 17,700 | 19,000 | 17,500
|
Trent | 50,700 | 43,600 | 48,500 | 42,800 | 39,400 | 37,400 | 34,800
|
West Midlands South | 15,500 | 13,300 | 16,100 | 15,600 | 19,900 | 20,200 | 19,300
|
West Yorkshire | 37,900 | 33,600 | 33,500 | 33,200 | 36,300 | 35,300 | 33,000
|
(54) Helped to live at home by means of any service recorded on Referrals, Assessments and Packages of Care (RAP) return P2s. This includes planned short term breaks, direct payments, professional support, transport and equipment and adaptations as well as home care, day care and meals services. Data for 199899 on this basis are estimated as are data for 19992000 for around a quarter of the 150 local authorities.
(55) Data as at March each year. Data for 199798 has been excluded as it is not comparable with later years.
(56) Data on the number of people helped to live at home in 200405 is not comparable to data for previous years. In 200405 restated guidance was issued to exclude people receiving services from grant-funded organisations who had not had a community care assessment.
Source:
KS1 and RAP proforma P2s
Drug Costs
John Hemming:
To ask the Secretary of State for Health (1) how many fees have been paid to pharmacists for each price category of (a) amlodipine, (b) simvastatin and (c) lisinopril (i) in each month of the last three financial years and (ii) to date in 200506; what the value was of each fee; and what the total payment was for each month for each price category of each drug; [48781]
(2) when (a) amlodipine, (b) simvastatin and (c) lisinopril went out of patent; [48782]
(3) what assessment she has made of the generic rates payable for (a) amlodipine, (b) simvastatin and (c) lisinopril since each drug went out of patent; [48783]
(4) what steps she plans to take to ensure that when drugs are out of patent fees are paid at a generic rate rather than a branded rate; and if she will make a statement. [48784]
13 Feb 2006 : Column 1761W
Jane Kennedy:
Data on the number of prescriptions and costs is recorded on a quarterly rather than monthly basis and is only currently available for the period up to September 2005. Table one, provides the number of items prescribed and their net ingredient cost for each of the medicines in each quarter. The drug tariff prices for each of these medicines during the period in question are provided in table two.
Data held by the Department records the following expiry dates for amlodipine, simvastatin and lisinopril:
The reimbursement prices for generic simvastatin and lisinopril followed the usual procedure and timeframe, moving from category C, reimbursement price based on a brand, to category A, reimbursement price based on a basket of generic suppliers, when the generic became available. However, it became apparent that there were significant differences between these generic reimbursement prices and the prices at which they could be purchased by community pharmacy contractors and dispensing doctors. These differences would normally be recovered by a discount inquiry, but these medicines entered the market
13 Feb 2006 : Column 1762W
after the last inquiry. Therefore, following a consultation, the Government reduced the prices of these medicines on two occasions; the first with effect from 1 December 2003 and the second with effect from September 2004.
Following patent expiry of amlodipine, the Department followed the usual procedure for setting a generic reimbursement price moving from category C to category A. However, the entry of amlodipine into category M was delayed 1 October 2005 by supply side instability.
The Department has already taken considerable action to ensure that off patent medicines are reimbursed appropriately. Following an unexpected increase in prices in 1999, the Department introduced a short term maximum price scheme whilst undertaking a wider consultation on the arrangements for the future supply and reimbursement of national health service generic medicines. Taking account of responses to this consultation, as part introduced a new category M into the drug tariff in April 2005 based on a new mechanism for setting reimbursement prices of commonly prescribed generics. The prices of category M medicines now reflect the average manufacturers' market prices after discount, but leave a margin of unrecovered discount as part of pharmacy funding. The prices for category M are recalculated quarterly.
Table 1: Number of prescription items and net ingredient cost of Amlodipine, Lisinopril and Simvastatin dispensed in the community in England. Quarterly data
| 2002
| 2003
|
| April-June | July-September | October-December | January-March | April-June | July-September | October-December
|
Number of prescription items (thousand)
|
Amlodipine | 1,695.7 | 1,728.9 | 1,790.3 | 1,747.0 | 1,830.4 | 1,872.9 | 1,943.4
|
Lisinopril | 1,558.5 | 1,578.3 | 1,612.9 | 1,550.8 | 1,606.6 | 1,634.2 | 1,669.3
|
Simvastatin | 1,712.9 | 1,859.6 | 2,005.6 | 2,043.2 | 2,239.8 | 2,435.7 | 2,652.7
|
Net ingredient cost (£ thousand)
|
Amlodipine | 34,758.0 | 35,400.4 | 36,683.9 | 35,655.5 | 37,214.3 | 40,500.6 | 43,337.6
|
Lisinopril | 21,925.4 | 22,288.1 | 22,871.3 | 21,039.9 | 20,866.6 | 20,209.5 | 18,254.5
|
Simvastatin | 61,003.7 | 66,808.5 | 72,698.8 | 74,423.1 | 81,742.0 | 81,890.8 | 71,024.2
|
| 2004
| 2005
|
| January-March | April-June | July-September | October-December | January-March | April-June | July-September
|
Number of prescription items (thousand)
|
Amlodipine | 1,934.5 | 2,010.8 | 2,073.1 | 2,173.5 | 2,138.5 | 2,287.9 | 2,354.5
|
Lisinopril | 1,639.6 | 1,684.3 | 1,717.9 | 1,763.6 | 1,694.6 | 1,788.0 | 1,808.4
|
Simvastatin | 2,756.3 | 3,018.4 | 3,297.9 | 3,608.4 | 3,623.1 | 3,966.3 | 4,272.2
|
Net ingredient cost (£ thousand)
|
Amlodipine | 42,947.8 | 42,188.3 | 40,534.5 | 37,345.3 | 35,521.5 | 36,328.2 | 36,671.9
|
Lisinopril | 15,698.4 | 16,077.2 | 14,703.7 | 11,705.8 | 11,192.3 | 5,965.0 | 5,365.3
|
Simvastatin | 63,548.2 | 69,749.3 | 66,109.1 | 51,471.9 | 51,814.6 | 20,572.1 | 15,940.2
|
Table 2: Reimbursement prices (pence)
| 2002
|
Drug | Pack | April | May | June | July | August | September | October | November | December
|
Amlodipine 5mg Tablets | 28 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185
|
Amlodipine l0mg Tablets | 28 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770
|
Lisinopril 2.5mg Tablets | 28 | 626 | 626 | 626 | 626 | 626 | 626 | 626 | 626 | 626
|
Lisinopril 5mg Tablets | 28 | 786 | 786 | 786 | 786 | 786 | 786 | 786 | 786 | 786
|
Lisinopril l0mg Tablets | 28 | 970 | 970 | 970 | 970 | 970 | 970 | 970 | 970 | 970
|
Lisinopril 20mg Tablets | 28 | 1,097 | 1,097 | 1,097 | 1,097 | 1,097 | 1,097 | 1,097 | 1,097 | 1,097
|
Simvastatin l0mg Tablets | 28 | 1,803 | 1803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803
|
Simvastatin 20mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2969
|
Simvastatin 40mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969
|
Simvastatin 80mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969
|
| 2003
|
Drug | Pack | January | February | March | April | May | June | July | August | September | October | November | December
|
Amlodipine 5mg Tablets | 28 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,185 | 1,304 | 1,304 | 1,304 | 1,304 | 1,304
|
Amlodipine l0mg Tablets | 28 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,770 | 1,947 | 1,947 | 1,947 | 1,947 | 1,947
|
Lisinopril 2.5mg Tablets | 28 | 616 | 608 | 595 | 582 | 571 | 571 | 560 | 550 | 539 | 526 | 514 | 375
|
Lisinopril 5mg Tablets | 28 | 773 | 764 | 752 | 736 | 720 | 720 | 708 | 696 | 670 | 666 | 649 | 495
|
Lisinopril l0mg Tablets | 28 | 954 | 942 | 930 | 914 | 898 | 898 | 884 | 860 | 846 | 840 | 823 | 677
|
Lisinopril 20mg Tablets | 28 | 1,079 | 1,066 | 1,054 | 1,035 | 1,012 | 1,012 | 998 | 978 | 957 | 951 | 936 | 750
|
Simvastatin l0mg Tablets | 28 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,803 | 1,659 | 1,630 | 1,518 | 1,456 | 1,199
|
Simvastatin 20mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,692 | 2,614 | 2,421 | 2,307 | 1,600
|
Simvastatin 40mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,809 | 2,774 | 2,681 | 2,620 | 2,100
|
Simvastatin 80mg Tablets | 28 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,969 | 2,908 | 2,908 | 2,877 | 2,877
|
13 Feb 2006 : Column 1763W
| 2004
|
Drug | Pack | January | February | March | April | May | June | July | August | September | October | November | December
|
Amlodipine 5mg Tablets | 28 | 1,304 | 1,304 | 1,304 | 1,304 | 1,304 | 1,304 | 1,211 | 1,167 | 1,092 | 1,056 | 1,004 | 1,284
|
Amlodipine l0mg Tablets | 28 | 1,947 | 1,947 | 1,947 | 1,947 | 1,947 | 1,947 | 1,792 | 1,727 | 1,583 | 1,534 | 1,445 | 926
|
Lisinopril 2.5mg Tablets | 28 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 375 | 289 | 289 | 289 | 289
|
Lisinopril 5mg Tablets | 28 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 347 | 347 | 347 | 347
|
Lisinopril l0mg Tablets | 28 | 677 | 677 | 677 | 677 | 677 | 677 | 677 | 677 | 404 | 404 | 404 | 404
|
Lisinopril 20mg Tablets | 28 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 549 | 549 | 549 | 549
|
Simvastatin l0mg Tablets | 28 | 1,199 | 1,199 | 1,199 | 1,199 | 1,199 | 1,199 | 1,199 | 1,199 | 578 | 578 | 578 | 578
|
Simvastatin 20mg Tablets | 28 | 1,600 | 1,600 | 1,600 | 1,600 | 1,600 | 1,600 | 1,600 | 1,600 | 780 | 780 | 780 | 780
|
Simvastatin 40mg Tablets | 28 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 2,100 | 1,560 | 1,560 | 1,560 | 1,560
|
Simvastatin 80mg Tablets | 28 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877 | 2,877
|
| 2005
|
Drug | Pack | January | February | March | April | May | June | July | August | September | October | November | December
|
Amlodipine 5mg Tablets | 28 | 870 | 962 | 889 | 889 | 889 | 889 | 889 | 889 | 889 | 548 | 548 | 548
|
Amlodipine l0mg Tablets | 28 | 1,233 | 1,362 | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 1,225 | 796 | 796 | 796
|
Lisinopril 2.5mg Tablets | 28 | 289 | 289 | 289 | 176 | 176 | 176 | 117 | 117 | 117 | 130 | 130 | 130
|
Lisinopril 5mg Tablets | 28 | 347 | 347 | 347 | 198 | 198 | 198 | 134 | 134 | 134 | 155 | 155 | 155
|
Lisinopril l0mg Tablets | 28 | 404 | 404 | 404 | 178 | 178 | 178 | 170 | 170 | 170 | 198 | 198 | 198
|
Lisinopril 20mg Tablets | 28 | 549 | 549 | 549 | 243 | 243 | 243 | 222 | 222 | 222 | 268 | 268 | 268
|
Simvastatin 10mg Tablets | 28 | 578 | 578 | 578 | 212 | 212 | 212 | 165 | 165 | 165 | 175 | 175 | 175
|
Simvastatin 20mg Tablets | 28 | 780 | 780 | 780 | 226 | 226 | 226 | 148 | 148 | 148 | 179 | 179 | 179
|
Simvastatin 40mg Tablets | 28 | 1,560 | 1,560 | 1,560 | 487 | 487 | 487 | 357 | 357 | 357 | 414 | 414 | 414
|
Simvastatin 80mg Tablets | 28 | 2,877 | 2,877 | 2,877 | 2,679 | 2,679 | 2,679 | 2,029 | 2,029 | 2,029 | 2,572 | 2,572 | 2,572
|
| | 2006
|
Drug | Pack | January | February
|
Amlodipine 5mg Tablets | 28 | 540 | 540
|
Amlodipine l0mg Tablets | 28 | 782 | 782
|
Lisinopril 2.5mg Tablets | 28 | 130 | 130
|
Lisinopril 5mg Tablets | 28 | 154 | 154
|
Lisinopril l0mg Tablets | 28 | 198 | 198
|
Lisinopril 20mg Tablets | 28 | 268 | 268
|
Simvastatin 10mg Tablets | 28 | 175 | 175
|
Simvastatin 20mg Tablets | 28 | 171 | 171
|
Simvastatin 40mg Tablets | 28 | 389 | 389
|
Simvastatin 80mg Tablets | 28 | 2,529 | 2,529
|